Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?-Reference-Cited by-同舟云学术

Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?

Published:2020-04-09 Issue:7 Volume:9 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Sommerstein Rami¹,Kochen Michael M.²,Messerli Franz H.³⁴⁵,Gräni Christoph³

Affiliation:

1. Department of Infectious Diseases Bern University Hospital Bern Switzerland

2. Institute of Family Medicine University of Freiburg Germany

3. Department of Cardiology Bern University Hospital Bern Switzerland

4. Jagiellonian University Krakow Poland

5. Division of Cardiology Mount Sinai Health Medical Center Icahn School of Medicine New York NY

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID‐19)—China, 2020;The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team;China CDC Wkly,2020

3. Angiotensin-Converting Enzyme Inhibitors in Hypertension

4. The novel coronavirus 2019 (2019‐nCoV) uses the SARS‐coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells;Hoffmann M;bioRxiv,2020

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19;Frontiers in Pharmacology;2024-07-12

2. The renin-angiotensin-aldosterone system inhibitor dilemma in COVID-19: balancing cardiovascular benefits and viral risks;Hypertension Research;2024-07-01

3. Pathogenic mechanisms of cardiovascular damage in COVID-19;Molecular Medicine;2024-06-19

4. The Epidemiology of COVID-19 Vaccine-Induced Myocarditis;Advances in Medicine;2024-04-18

5. Current status of hypertension care and management in the Philippines;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-04